Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
Alopecia areata (AA) is a chronic, tissue-specific autoimmune disorder, characterized by non-scaring hair loss, with a global prevalence of approximately 2%. Typically, it affects a young population, with initial onset frequently occurring before the age of 30 years. Even though the exact pathogenes...
Kaydedildi:
Asıl Yazarlar: | , , |
---|---|
Materyal Türü: | Kitap |
Baskı/Yayın Bilgisi: |
BioExcel Publishing Ltd,
2023-09-01T00:00:00Z.
|
Konular: | |
Online Erişim: | Connect to this object online. |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
Yer Numarası: |
A1234.567 |
---|---|
Kopya Bilgisi 1 | Kütüphanede |